USA Target German Drug Prices
The United States is investigating Germany’s drug prices. The US believes drug costs are too high for American patients. This investigation focuses on rebates offered by German insurers.
The United States government started a trade probe against Germany’s pharmaceutical industry. The probe is about the cost of new medicines. US health insurers are saying companies give big discounts to German firms. These discounts lead to higher prices for US patients. The investigation looks at how Germany sets drug prices and how it affects the US market.
Summarized from the sources above. Read the originals for the full story.
Highlights
US Trade Probe Launched
The United States started a trade probe into Germany’s pharmaceutical industry.
Disagreement on Drug Costs
The US argues about high drug prices and who pays for them.
Rebates Under Investigation
US health insurers are accused of forcing high rebates.
Germany’s Pricing Practices
The investigation focuses on Germany’s drug pricing methods.
Impact on US Patients
US patients pay too much, according to Washington.